Prognostic significance of cyclin E and p53 protein overexpression in carcinoma of the renal pelvis and ureter

British Journal of Cancer

Volumn 77, Issue 5, 1998, Pages 783-788

  Furihata, M ^a   Ohtsuki, Y ^a   Sonobe, H ^a   Shuin, T ^a   Yamamoto, A ^b   Terao, N ^b   Kuwahara, M ^c  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b Kochi Takasu Hospital   (Japan)

^c Fujisaki Hospital   (Japan)

Author keywords

Cyclin E; Immunohistochemistry; p53; Patient prognosis; Transitional cell carcinoma

Indexed keywords

CYCLIN E; PROTEIN P53;

ADULT; AGED; ARTICLE; CELL NUCLEUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY PELVIS CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA; URETER CARCINOMA;

EID: 0031886641     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.127     Document Type: Article

References (35)

1. Akama Y, Yasui W, Kuniyasu H, Yokozaki H, Akagi M, Tahara H, Ishikawa T and Tahara E (1996) Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines. Jpn J Cancer Res 87: 824-830
2. Barbareschi M, Caffo O, Doglioni C, Marchetti A, Buttitta F, Leek R, Bevilacqua G, Dalla Palma P and Harris AL (1996) p21 Waf 1 immunohistochemical expression in breast carcinoma: correlation with clinic-pathologic data, ER status, MIB 1 expression, p53 gene and protein alteration and relapse free survival. Br J Cancer 74: 208-215
3. Betticher D, Thatcher N, Altermatt HJ, Hoban P, Ryder WDJ and Heighway J (1995) Alternate splicing produces a novel cyclin D1 transcript. Oncogene 11: 1005-1011
4. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CKW, Musgrove EA and Sutherland RL (1993) Expression and amplification of cyclin genes in human breast cancer. Oncogene 8: 2127-2133
5. Cong J, Ardelt B, Traganos F and Darzynkiewicz Z (1994) Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumour cell lines. Cancer Res 54: 4285-1288
6. Cordon-Cardo C (1995) Mutation of cell cycle regulators. Biological and clinical implications lor human neoplasia. Am J Pathol 147: 545-560
7. Courjal F, Louason G, Speiser P, Katsaros D, Zeillinger R and Theillet C (1996) Cyclin gene amplification and overexpression in breast and ovarian cancer: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumours. Int J Cancer (Pred Oncol) 69: 247-253
8. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH and Reid BJ (1995) A p53-dependent mouse spindle checkpoint. Science 267: 1353-1356
9. Elbendary AA, Cirisano FD, Evans AC, Davis JPL, Iglehart JD, Marks JR and Berchuck A (1996) Relationship between p21 expression and mutation of the p53 tumour suppressor gene in normal and malignant ovarian epithelial cells. Clin Cancer Res 2: 1571-1575
10. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer H, Kinzler KW and Vogelstein B (1993) WAF1, a potential mediator of p53 tumour suppression. Cell 75: 817-825
11. Elledge SJ and Spottswood MR (1991) A new human p34 protein kinase, CDK2, identified by complimentation of a CDC28 mutation in Saccharomyces cerevisiae, is a homolog of Xenopus Eg1. EMBO J 10: 2653-2659
12. Furihata M, Inoue K, Ohtsuki Y, Hashimoto H, Terao N and Fujita Y (1993) High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res 53: 4823-4827
13. Furihata M, Sonobe H and Ohtsuki Y (1995a) The aberrant p53 protein (review). Int J Oncol 6: 1209-1226
14. Furihata M, Yamasaki I, Ohtsuki Y, Sonobe H, Morioka M, Yamamoto A, Terao N, Kuwahara M and Fujisaki N (1995b) p53 and human papillomavirus DNA in renal pelvic and ureteral carcinoma including dysplastic lesions. Int J Cancer (Pred Oncol) 64: 298-303
15. Furihata M, Sonobe H, Ohtsuki Y, Yamashita M, Morioka M, Yamamuto A, Terao N, Kuwahara M and Fujisaki N (1996) Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia. J Pathol 178: 133-139
16. Gillett C, Ranti V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D and Peters G (1994) Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54: 1812-1817
17. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816
18. Hunter T and Pines J (1991) Cyclins and cancer. A review. Cell 66: 1071-1074
19. Ishikawa T, Furihata M, Ohtsuki Y, Murakami H, Inoue A and Ogoshi S (1998) Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human esophageal squamous cell carcinoma. Br J Cancer 77: 92-97
20. Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J and Cardesa A (1994) PRAD-1/Cyclin D1 gene amplification correlates with messenger RNA overexpression and tumour progression in human laryngeal carcinomas. Cancer Res 54: 4813-4817
21. Jiang W, Zhang YJ, Kahn SM, Hollstein MC, Santella RM, Lu SH, Harris CC, Montesano R and Weinstein IB (1993) Altered expression of cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 90: 9026-9030
22. Jiang H, Lin J, Su Z. Collart FR, Huberman E and Fisher PB (1994) Induction of differentiation in human promyclocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9: 3397-3406
23. Keyomarsi K and Pardee AB (1993) Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 90: 1112-1116
24. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ and Pardee AB (1994) Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54: 380-385
25. Keyomarsi K, Conte Jr D, Toyofuku W and Fox MP (1995) Deregulation of cyclin E in breast cancer. Oncogene 11: 941-950
26. Leach KS, Elledge SJ, Sherr CJ, Willson JKV, Markowitz S, Kinzler KW and Vogelstein B (1993) Amplification of cyclin genes in colorectal carcinomas. Cancer Res 53: 1986-1989
27. Michalides R, van Veelen N, Hart A, Loftus B, Wienjens E and Balm A (1995) Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55: 975-978
28. Michiele P, Chedid M, Lin D, Mercer WE and Givol D (1994) Induction of WAF1/CTP1 by a p53-independent pathway. Cancer Res 54: 3391-3395
29. cdc2. Cell 58: 833-846
30. Rosenblatt J, Gu Y and Morgan DO (1992) Human cyclin-dependent kinase 2 is activated during the S and G2 phase of the cell cycle and associates with cyclin A. Proc Natl Acad Sci USA 89: 2824-2828
31. Sheikh MS, Li XS, Chen JC, Shao ZM, Ordonez JV and Fontana JA (1994) Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathway. Oncogene 9: 3407-3415
32. Sidransky D, Fschenbach AV, Tsai YC, Jones P, Summerhayes I, Marshall F, Paul M, Green P, Hamilton SR, Frost P and Vogelstein B (1991) Identification of p53 gene mutations in bladder cancers and urine samples. Science 252: 706-709
33. Terrell RB, Cheville JC, See WA and Cohen MB (1995) Histopathological features and p53 nuclear protein staining as predictors of survival and tumour recurrence in patients with transitional cell carcinoma of the renal pelvis. J Urol 154: 1342-1347
34. Tsai LH, Harlow E and Meyerson M (1991) Isolation of the human cdk2 gene that encodes the cyclin A-and adenovirus ElA-associated p33 kinase. Nature 353: 174-177
35. Yasui W, Kuniyasu H, Yokozaki H, Semba S, Shimamolo F and Tahara E (1996) Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 antigen and p53 protein. Virchow Arch 429: 13-19